Introduction The Institute of Medicine prioritizes active family and clinician participation in treatment decisions, known as shared decision making (SDM). In this article we report the decision-making experiences for parents of children who had a solid organ transplant. Method We performed a prospective longitudinal mixed methods study at five major U.S. children\u27s medical centers. Qualitative interview data were obtained at 3 weeks, 3 months, and 6 months after hospital discharge following the child\u27s transplant. Results Forty-eight parents participated in the study. Three themes were identified: (a) Parents expect to participate in SDM; (b) parents seek information to support their participation in SDM; and (c) attributes of prov...
BACKGROUND: In pediatric hematopoietic stem cell transplantation (HSCT), the end-of-life (EOL) phase...
AbstractPediatric hematopoietic stem cell transplantation (HSCT) offers cure for high-risk malignanc...
Objective A proportion of children die, making them potentially eligible to be organ/tissue donors. ...
Purpose To explore parents’ experiences of the transition from hospital to home and complex chronic ...
Pediatric SOT recipients are medically fragile and present with complex care issues requiring high-l...
Transplant providers are challenged to determine appropriate interventions for patients and families...
Purpose: Patient-reported outcome measures (PROMs) are standardized instruments used to collect data...
Achievement of optimal quality in today’s healthcare environment practices means that clinical pract...
Solid‐organ transplantation is the treatment of choice for end‐stage organ failure. Parents of pedia...
Abstract: Poor discharge transition is evidence of a gap between evidence‐based practices and curre...
Close family members of organ transplant recipients are frequently implicated in supporting their lo...
Title on title page: Decision-making in pediatric hematopoeitic cell transplantion, Title on signatu...
Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/87036/1/j.1399-3046.2011.01499.x.pd
Abstract Problem: At a comprehensive pediatric medical center in the Midwest, there are currently n...
Abstract Background Shared decision-making (SDM) is rarely implemented in pediatric practice. Pediat...
BACKGROUND: In pediatric hematopoietic stem cell transplantation (HSCT), the end-of-life (EOL) phase...
AbstractPediatric hematopoietic stem cell transplantation (HSCT) offers cure for high-risk malignanc...
Objective A proportion of children die, making them potentially eligible to be organ/tissue donors. ...
Purpose To explore parents’ experiences of the transition from hospital to home and complex chronic ...
Pediatric SOT recipients are medically fragile and present with complex care issues requiring high-l...
Transplant providers are challenged to determine appropriate interventions for patients and families...
Purpose: Patient-reported outcome measures (PROMs) are standardized instruments used to collect data...
Achievement of optimal quality in today’s healthcare environment practices means that clinical pract...
Solid‐organ transplantation is the treatment of choice for end‐stage organ failure. Parents of pedia...
Abstract: Poor discharge transition is evidence of a gap between evidence‐based practices and curre...
Close family members of organ transplant recipients are frequently implicated in supporting their lo...
Title on title page: Decision-making in pediatric hematopoeitic cell transplantion, Title on signatu...
Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/87036/1/j.1399-3046.2011.01499.x.pd
Abstract Problem: At a comprehensive pediatric medical center in the Midwest, there are currently n...
Abstract Background Shared decision-making (SDM) is rarely implemented in pediatric practice. Pediat...
BACKGROUND: In pediatric hematopoietic stem cell transplantation (HSCT), the end-of-life (EOL) phase...
AbstractPediatric hematopoietic stem cell transplantation (HSCT) offers cure for high-risk malignanc...
Objective A proportion of children die, making them potentially eligible to be organ/tissue donors. ...